ThirtyFiveBio Limited

ThirtyFiveBio Limited is a biotech company in United Kingdom, founded in 2021. It has raised $20.0M across 2 rounds, most recently a Bridge in April 2025.

ThirtyFiveBio | Home

Founded
2021
Business Model
B2B
Total Funding
$20.0M
Last Round
BridgeApr 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

ThirtyFiveBio develops a gut epithelial shield for patients with ulcerative colitis, using GPR35 inhibition to protect gut epithelial cells from inflammatory attack. Its approach focuses on reducing epithelial dysfunction and damage. The company aims to address underlying disease causality in a condition where anti-inflammatory medicines provide limited benefit for many patients.

Summary

It has raised $20.0M in total across 2 rounds, most recently a Bridge round in Apr 2025. Investors include AbbVie Ventures, M:M Bio and Canaan Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
BridgeBridge RoundApr 2025

Sign up to see all 2 events

Funding: Seed through Bridge. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ThirtyFiveBio Limited on Indexed.vc
<a href="https://indexed.vc/companies/thirtyfivebio-limited"><img src="https://indexed.vc/api/badge/company/thirtyfivebio-limited" alt="ThirtyFiveBio Limited on Indexed.vc" width="260" height="76" /></a>